Trial watch: Immunostimulatory cytokines in cancer therapy

Tumor-targeting immune responses provide a significant contribution to (when they do not entirely account for) the clinical activity of diverse antineoplastic regimens, encompassing not only a large panel of immunotherapeutic strategies but also conventional cytotoxic molecules, targeted anticancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Vacchelli, Erika, Aranda, Fernando, Obrist, Florine, Eggermont, Alexander, Galon, Jérôme, Cremer, Isabelle, Zitvogel, Laurence, Kroemer, Guido, Galluzzi, Lorenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2014
Materias:
Author's View
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4091551/
https://www.ncbi.nlm.nih.gov/pubmed/25083328
http://dx.doi.org/10.4161/onci.29030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4091551/
https://www.ncbi.nlm.nih.gov/pubmed/25083328
http://dx.doi.org/10.4161/onci.29030

Ejemplares similares